Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Evogene Ltd EVGN

Healthcare Biotechnology
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:EVGN)

Evogene Reports Third Quarter 2024 Financial Results

PR Newswire 5 days ago

Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results

PR Newswire 7 days ago

Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials

PR Newswire November 12, 2024

Evogene Schedules Third Quarter 2024 Financial Results Release

PR Newswire November 7, 2024

Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design

PR Newswire October 31, 2024

Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya

PR Newswire October 29, 2024

Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals

PR Newswire September 30, 2024

Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement

PR Newswire August 23, 2024

Evogene Reports Second Quarter 2024 Financial Results

PR Newswire August 22, 2024
View More News ››

Opinion & Analysis (NDAQ:EVGN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:EVGN)

Evogene Reports Third Quarter 2024 Financial Results

News; $EVGN Evogene Reports Third Quarter 2024 Financial ResultsEvogene Reports Third Quarter 2024 Financial Results PR Newswire...
whytestocks - 4 days ago

Evogene Schedules Second Quarter 2024 Financial Results Rele

News; $EVGN Evogene Schedules Second Quarter 2024 Financial Results ReleaseEvogene Schedules Second Quarter 2024 Financial Results...
whytestocks - August 12, 2024

Buy Recommendation Issued On EVGN By Alliance Global Partner

BREAKING NEWS: $EVGN Buy Recommendation Issued On EVGN By Alliance Global Partners2024-06-27 08:15:04 ET Alliance Global Partners...
whytestocks - June 27, 2024

Evogene Reports Fourth Quarter and Full Year 2023 Financial

NEWS: $EVGN Evogene Reports Fourth Quarter and Full Year 2023 Financial ResultsEvogene Reports Fourth Quarter and Full Year 2023...
whytestocks - March 7, 2024

Evogene Schedules Fourth Quarter 2023 Financial Results Rele

JUST IN: $EVGN Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024Evogene...
whytestocks - February 26, 2024

AgPlenus Announces Licensing & Collaboration Agreement with

News; $EVGN AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control...
whytestocks - February 21, 2024
View more Bullboard ››

Biosenta Inc.

Biosenta Inc.

Biosenta Inc. is engaged in developing, producing, and manufacturing an array of chemical compounds for household and ...
View More »